Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society
Open accessThe DOI matches its Crossref record; 134 of the 141 references it cites were found in a registry or an index; 90 of the 190 sources its claims cite were checked for support.
Abstract
OBJECTIVE: To review the evidence about the impact of hypoglycemia on patients with diabetes that has become available since the past reviews of this subject by the American Diabetes Association and The Endocrine Society and to provide guidance about how this new information should be incorporated into clinical practice. PARTICIPANTS: Five members of the American Diabetes Association and five members of The Endocrine Society with expertise in different aspects of hypoglycemia were invited by the Chair, who is a member of both, to participate in a planning conference call and a 2-day meeting that was also attended by staff from both organizations. Subsequent communications took place via e-mail and phone calls. The writing group consisted of those invitees who participated in the writing of the manuscript. The workgroup meeting was supported by educational grants to the American Diabetes Association from Lilly USA, LLC and Novo Nordisk and sponsorship to the American Diabetes Association from Sanofi. The sponsors had no input into the development of or content of the report. EVIDENCE: The writing group considered data from recent clinical trials and other studies to update the prior workgroup report. Unpublished data were not used. Expert opinion was used to develop some conclusions. CONSENSUS PROCESS: Consensus was achieved by group discussion during conference calls and face-to-face meetings, as well as by iterative revisions of the written document. The document was reviewed and approved by the American Diabetes Association's Professional Practice Committee in October 2012 and approved by the Executive Committee of the Board of Directors in November 2012 and was reviewed and approved by The Endocrine Society's Clinical Affairs Core Committee in October 2012 and by Council in November 2012. CONCLUSIONS: The workgroup reconfirmed the previous definitions of hypoglycemia in diabetes, reviewed the implications of hypoglycemia on both short- and long-term outcomes, considered the implications of hypoglycemia on treatment outcomes, presented strategies to prevent hypoglycemia, and identified knowledge gaps that should be addressed by future research. In addition, tools for patients to report hypoglycemia at each visit and for clinicians to document counseling are provided.
Overview
CoChat Summary
TL;DR
This ADA/Endocrine Society workgroup report updates definitions, risks, and prevention strategies for hypoglycemia in diabetes, with a strong emphasis on avoiding severe episodes and hypoglycemia unawareness. It argues for individualized glycemic targets, better monitoring and education, and further research on outcomes, measurement, and new therapies.
Key findings
- The workgroup defines iatrogenic hypoglycemia as all episodes of abnormally low plasma glucose that expose the person to potential harm, and recommends an alert value of ≤70 mg/dL (≤3.9 mmol/L) for patients at risk; it also classifies episodes as severe, documented symptomatic, asymptomatic, probable symptomatic, or pseudo-hypoglycemia.
- Severe hypoglycemia rates reported in the paper ranged from 115 to 320 per 100 patient-years in type 1 diabetes and 35 to 70 per 100 patient-years in type 2 diabetes; because type 2 diabetes is more common, most hypoglycemia episodes occur in people with type 2 diabetes.
- In ACCORD, intensive glycemic control produced threefold higher hypoglycemia and a 20% increase in mortality; post hoc analyses in ACCORD found severe hypoglycemia had a hazard ratio of 1.41 (95% CI 1.03–1.93) for death.
- In hospitalized patients, one retrospective study found 10.5% of 31,970 general-ward admissions had at least one hypoglycemic episode (≤70 mg/dL), and severe hypoglycemia (≤50 mg/dL) was associated with increased length of stay and greater odds of inpatient death and death within 1 year of discharge.
Methods
- This is a workgroup report/consensus document, not an experimental study; five ADA and five Endocrine Society experts were invited, held a planning call and a 2-day meeting, and developed the manuscript through discussion and iterative revisions.
- The group reviewed recent clinical trials and other studies published since the prior reports; unpublished data were not used, and some conclusions relied on expert opinion.
- Consensus was reached by group discussion and was reviewed/approved by both organizations’ committees in October and November 2012.
Limitations
- The paper states that unpublished data were not used, and that expert opinion was used to develop some conclusions.
- The text makes evident that some evidence is observational, post hoc, or limited by small studies, so causal inference is uncertain in several areas (e.g., mortality, cognition); this is an inference from the paper’s cited evidence, not a limitation explicitly stated in one place.
- The paper explicitly notes gaps in knowledge on hypoglycemia outcomes, mechanisms, and prevention, indicating that several recommendations are based on incomplete evidence.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
59 Valid · 5 Not valid · 33 Not checked · 7 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“There is convincing evidence that formal training programs that teach patients to replace insulin “physiologically” by giving background and mealtime/correction doses of insulin can reduce the risk of severe hypoglycemia.”
§ Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society > What strategies are known to prevent hypoglycemia, and what are the clinical recommendations for those at risk for hypoglycemia? > Patient education
What the sources say
- Supportedcites [100] Mühlhauser, 2002, Patient education—evaluation of a complex intervention, Diabetologia source
The Modelling section describes a structured programme teaching patients to adjust insulin doses, using NPH insulin twice daily and regular insulin before meals. The Long-term implementation section reports decreased rates of severe hypoglycaemia in patients with Type I diabetes and says several prospective studies observed that reduction. The paper supports that such programmes can reduce the risk, although not every evaluation found a reduction. (LLM, conf=0.90)
- Partly supportedcites [101] Bott, 1997, Intensified insulin therapy and the risk of severe hypoglycaemia, Diabetologia sourceExperimental — accuracy not yet measured
The Subjects and methods passage describes structured training in background and mealtime insulin dosing, with patients adjusting doses for glucose and carbohydrate intake. The Results and Discussion report fewer severe hypoglycaemic episodes after the programme, but describe the reduction as an association; they do not establish that training itself caused it. The claim’s description of this as convincing evidence that the programmes can reduce risk is therefore stronger than the paper’s finding. (LLM, conf=0.84)
- Supportedcites [102] Sämann, 2005, Glycaemic control and severe hypoglycaemia following training in flexible, intensive insulin therapy to enable dietary freedom in people with type 1 diabetes: a prospective implementation study, Diabetologia source
The Subjects and methods section describes a structured course teaching background insulin injections and meal-by-meal dose adjustments based on blood glucose and carbohydrate intake. The Abstract reports that severe hypoglycaemia fell from 0.37 to 0.14 events per patient per year after training among people with type 1 diabetes. (LLM, conf=0.92)
- Disputedcites [103] DAFNE Study Group, 2002, Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial, BMJ sourceExperimental — accuracy not yet measured
The skills course section describes training patients to adjust insulin to their meals. But the paper reports that severe hypoglycaemia remained unchanged; the Discussion says there was no significant increase, not a reduction in risk. The claimed risk reduction is therefore contrary to the reported finding. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
- Not checked — no full text of the sourcecites [104] McIntyre, 2010, Dose adjustment for normal eating (DAFNE)—an audit of outcomes in Australia, Med J Aust source
- Partly supportedcites [105] Hopkins, 2012, Improved biomedical and psychological outcomes 1 year after structured education in flexible insulin therapy for people with type 1 diabetes: the U.K. DAFNE experience, Diabetes Care sourceExperimental — accuracy not yet measured
The Results and Conclusions (pages not provided) report fewer severe hypoglycemia episodes after DAFNE, a structured education program for adults with type 1 diabetes. The paper describes adjusting insulin to carbohydrate intake, but does not specify the claimed background and mealtime/correction-dose teaching. Its evidence is also a retrospective audit based on self-reported hypoglycemia, which qualifies the claim of ‘convincing evidence.’ (LLM, conf=0.82)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“glycemic thresholds for symptoms of hypoglycemia (among other responses) shift to lower plasma glucose concentrations after recent antecedent hypoglycemia (9–12)”
§ Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society > How should hypoglycemia in diabetes be defined and reported?
What the sources say
- Not checked — no full text of the sourcecites [9] Amiel, 1988, Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release, Diabetes source
- Supportedcites [10] Dagogo-Jack, 1993, Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia, J Clin Invest source
The Discussion states that after an episode of hypoglycemia, the authors found elevated glycemic thresholds for neurogenic and neuroglycopenic symptoms, including in patients with IDDM in the present study. Its terminology indicates that an elevated threshold means symptoms occur at a lower plasma glucose concentration. The Results also report reduced symptom responses after antecedent hypoglycemia. (LLM, conf=0.90)
- Not checked — no full text of the sourcecites [11] Davis, 1997, Effects of differing antecedent hypoglycemia on subsequent counterregulation in normal humans, Diabetes source
- Not checked — no full text of the sourcecites [12] Heller, 1991, Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans, Diabetes source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In critical care units, where the accuracy of POC meters is particularly crucial, their performance may be compromised by medications (vasopressors, acetaminophen), treatments (oxygen), and clinical states (hypotension, anemia) (17).”
§ Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society > How should hypoglycemia in diabetes be defined and reported? > The challenge of measuring glucose accurately
What the sources say
- Partly supportedcites [17] Klonoff, 2011, Continuous glucose monitoring: an Endocrine Society Clinical Practice Guideline, J Clin Endocrinol Metab sourceExperimental — accuracy not yet measured
Section 1.1 Evidence says supplemental oxygen can cause falsely low readings with glucose-oxidase meters and identifies acetaminophen, pressor use, and hypotension as potential concerns for POC testing in critically ill patients. It also reports an accuracy discrepancy among patients with hypotension or pressor treatment. The cited passages do not address anemia as a cause of compromised meter performance. (LLM, conf=0.88)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“A single threshold value for plasma glucose concentration that defines hypoglycemia in diabetes cannot be assigned because glycemic thresholds for symptoms of hypoglycemia (among other responses) shift to lower plasma glucose concentrations after recent antecedent hypoglycemia (9–12) and to higher plasma glucose concentrations in patients with poorly controlled diabetes and infrequent hypoglycemia”
§ Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society > How should hypoglycemia in diabetes be defined and reported?
What the sources say
- Not checked — no full text of the sourcecites [9] Amiel, 1988, Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release, Diabetes source
- Supportedcites [10] Dagogo-Jack, 1993, Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia, J Clin Invest source
The Discussion (p. 823) reports that antecedent hypoglycemia changes the glycemic threshold for symptoms in patients with insulin-dependent diabetes. The Discussion also reports symptoms at higher plasma glucose concentrations in patients with poorly or moderately controlled diabetes. Together, these findings support the claim that no single symptom-based plasma glucose threshold applies across these circumstances. (LLM, conf=0.91)
- Not checked — no full text of the sourcecites [11] Davis, 1997, Effects of differing antecedent hypoglycemia on subsequent counterregulation in normal humans, Diabetes source
- Not checked — no full text of the sourcecites [12] Heller, 1991, Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans, Diabetes source
- Not checked — no full text of the sourcecites [13] Boyle, 1988, Plasma glucose concentrations at the onset of hypoglycemic symptoms in patients with poorly controlled diabetes and in nondiabetics, N Engl J Med source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“Hypoglycemia puts patients at risk for injury and death.”
- Also stated in: § What are the implications of hypoglycemia on both short- and long-term outcomes in people with diabetes? · plain
“There is no doubt that hypoglycemia can be fatal (26).”
§ Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society > How should hypoglycemia in diabetes be defined and reported?
What the sources say
- Supportedcites [26] Cryer, 2011, Death during intensive glycemic therapy of diabetes: mechanisms and implications, Am J Med source
In the main text (page unavailable), Cryer states that iatrogenic hypoglycemia causes recurrent morbidity in people with diabetes and is sometimes fatal. This supports the broad claim that hypoglycemia puts these patients at risk of harm and death. (LLM, conf=0.88)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § What are the implications of hypoglycemia on both short- and long-term outcomes in people with diabetes? · plain
76 more claims · 43 with their cited sources checked
Create a free account to see all 104 claims and to verify the 4 references still open.
- It may state two separate claims as one. 21
- Probably not a substantial claim. 2
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Postprandial hyperglycemia and resultant compensatory hyperinsulinemia from high dietary glycemic load can lower plasma glucose to concentrations that compromise brain glucose, w70 mg/dL (3.8 mmol/L) (36), triggering the secretion of autonomic counterregulatory hormones such as adrenaline, cortisol, glucagon, and growth hormone (37).”
From High glycemic index diet as a risk factor for depression: analyses from the Women’s Health Initiative (2015) · cites this paper as [36]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Risks for hypoglycemia, particularly level 3 hypoglycemia, include longer duration of diabetes, older age, history of recent level 3 hypoglycemia, alcohol ingestion, exercise, lower education levels, lower household incomes (41), chronic kidney disease, and IAH (103-105).”
From The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) (2021) · cites this paper as [103]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Recurrent hypoglycaemia results in an increased likelihood of hypoglycaemia unawareness and subsequent severe hypoglycaemic events, since recurrent hypoglycaemia reduces the glucose concentration that triggers the counter-regulatory responses to return to euglycaemia.106”
From Type 1 diabetes (2018) · cites this paper as [106]
The cited source says what the claim attributes to it.
In the citing paper
“Hypoglycemia is a frequent and dangerous complication of diabetes (1), causing changes in physiological parameters (2,3).”
From Noninvasive Hypoglycemia Detection in People With Diabetes Using Smartwatch Data (2023) · cites this paper as [1]
The cited source says what the claim attributes to it.
In the citing paper
“Individualized glucose targets, patient education, nutrition intervention (e.g., bedtime snack to prevent overnight hypoglycemia when specifically needed to treat low blood glucose), physical activity management, medication adjustment, glucose monitoring, and routine clinical surveillance may improve patient outcomes (94).”
From 6. Glycemic Targets: Standards of Care in Diabetes—2023 (2023) · cites this paper as [94]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Self-check results appear here once an independent check has confirmed them.
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
In the paper
“Deakin T McShane CE Cade JE Williams RD Group based training for self-management strategies in people with type 2 diabetes mellitus. Cochrane Database Syst Rev 2005; 2: CD003417 15846663”
Cited work 10.1002/14651858.cd003417.pub2 · retracted 2015-06-30 · notice 10.1002/14651858.cd003417.pub3 · this paper published 2013-04-13
Citations
Cites
1 retracted
Group based training for self-management strategies in people with type 2 diabetes mellitus
Deakin, T. A., McShane, C. E., Cade, J. E., & Williams, R. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003417.pub2 · Cited by 862
RetractedIntensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
Intensive versus Conventional Glucose Control in Critically Ill Patients
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810625 · Cited by 5,119
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762 · cited 1×
“In VADT, a recent severe hypoglycemic event was the strongest independent predictor of death at 90 days (3).”
BackgroundInzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2012) · Diabetologia · doi:10.1007/s00125-012-2534-0 · Cited by 3,919 · cited 2×
“event of troublesome hypoglycemia (96).”
BackgroundIntensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2012) · Diabetes Care · doi:10.2337/dc12-0413 · Cited by 3,207
Research works printed but not linked: 2
- Reno, 2011, Deaths due to severe hypoglycemia are exacerbated by diabetes and ameliorated by hypoglycemic pre-conditioning (Abstract), Diabetes, 60, A81
- Aubert, 1995, Diabetes-Related Hospitalization and Hospital Utilization
Cited by
Items 201–300 of 1,392
Marso, S. P., McGuire, D. K., Zinman, B., Poulter, N. R., Emerson, S. S., Pieber, T. R., Pratley, R. E., Haahr, P.-M., Lange, M., Frandsen, K. B., et al. (2016) · American Heart Journal · doi:10.1016/j.ahj.2016.06.004 · Cited by 65
Karstoft, K., Clark, M. A., Jakobsen, I., Müller, I. A., Pedersen, B. K., Solomon, T. P. J., & Ried‐Larsen, M. (2016) · Diabetologia · doi:10.1007/s00125-016-4170-6 · Cited by 74
Exercise‐induced hypoglycaemia in type 1 diabetes
Cockcroft, E., Narendran, P., & Andrews, R. C. (2020) · Experimental Physiology · doi:10.1113/ep088219 · Cited by 80
Dubourg, J., Ueki, K., Grouin, J., & Fouqueray, P. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14285 · Cited by 67
“9 mmol/L) and severe hypoglycaemia (an event requiring the assistance of another person to actively administer carbohydrates, glucagon or take other corrective actions).(17) All efficacy and safety laboratory measurements were assayed at a central laboratory by technicians blinded to treatment allocation.”
Urva, S., Quinlan, T., Landry, J., Martin, J., & Loghin, C. (2021) · Clinical Pharmacokinetics · doi:10.1007/s40262-021-01012-2 · Cited by 64
“Hypoglycemic events were verified by plasma glucose concentration and/or required third-party assistance according to the American Diabetes Association guidance [40].”
MethodVigersky, R. A. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814565661 · Cited by 63
Self-citationHausner, H., Derving Karsbøl, J., Holst, A. G., Jacobsen, J. B., Wagner, F.-D., Golor, G., & Anderson, T. W. (2017) · Clinical Pharmacokinetics · doi:10.1007/s40262-017-0532-6 · Cited by 62
“Probable symptomatic hypoglycaemia was defined as an episode during which symptoms of hypoglycaemia were not accompanied by a low plasma glucose determination but presumably caused by a low plasma glucose level [27].”
BackgroundMethodLong-term Outcomes in Youths with Diabetes Mellitus
White, N. H. (2015) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2015.04.004 · Cited by 79
Berkowitz, S. A., Karter, A. J., Lyles, C. R., Liu, J. Y., Schillinger, D., Adler, N. E., Moffet, H. H., & Sarkar, U. (2014) · Journal of Health Care for the Poor and Underserved · doi:10.1353/hpu.2014.0106 · Cited by 62
“6) Medication Type Insulin 3,142 (22) Metformin only 2,727 (19) Secretagogue only 2,284 (16) Mixed Oral Meds 6,205 (43) Diabetes Duration (years) 10 (8) Estimated glomerular filtration rate (eGFR) in ml/ min by MDRD equation eGFR >60 9,156 (64) eGFR 30– 60 3,037 (21) eGFR <30 354 (3) SelfMonitoring of Blood Glucose (S…”
BackgroundIs hypoglycemia fear independently associated with health-related quality of life?
Shi, L., Shao, H., Zhao, Y., & Thomas, N. A. (2014) · Health and Quality of Life Outcomes · doi:10.1186/s12955-014-0167-3 · Cited by 64
“Discussion In patients with type 2 diabetes treated with antihyperglycemic therapy, hypoglycemia imposes a significant physical and psychological burden [28].”
BackgroundZhong, V. W., Juhaeri, J., Cole, S. R., Kontopantelis, E., Shay, C. M., Gordon-Larsen, P., & Mayer-Davis, E. J. (2017) · Diabetes Care · doi:10.2337/dc16-2680 · Cited by 62
“leading to very different hypoglycemia risk (1).”
BackgroundInfluentialKo, S.-H., Park, Y.-M., Yun, J.-S., Cha, S.-A., Choi, E.-K., Han, K., Han, E., Lee, Y.-H., & Ahn, Y.-B. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.09.009 · Cited by 62
Hood, R. C., Arakaki, R. F., Wysham, C., Li, Y. G., Settles, J. A., & Jackson, J. A. (2015) · Endocrine Practice · doi:10.4158/ep15612.or · Cited by 61
13. Diabetes Care in the Hospital, Nursing Home, and Skilled Nursing Facility
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc15-s016 · Cited by 67
“Tracking such episodes and analyzing their causes are important quality-improvement activities (22).”
BackgroundGuideline for the Management of Diabetes Mellitus in the Elderly in China (2024 Edition)
Guo, L., & Xiao, X. (2024) · Aging Medicine · doi:10.1002/agm2.12294 · Cited by 79
“210 The above conditions, if occurring in the nighttime, are extremely dangerous because it is difficult to identify and timely treat the disorders.”
BackgroundRooijackers, H. M. M., Wiegers, E. C., Tack, C. J., van der Graaf, M., & de Galan, B. E. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2079-8 · Cited by 59
Genuth, S. (2015) · Diabetes Care · doi:10.2337/dc14-0565 · Cited by 60
“considered in the event of troublesome hypoglycemia” (20).”
Rickels, M. R., Peleckis, A. J., Markmann, E., Dalton-Bakes, C., Kong, S. M., Teff, K. L., & Naji, A. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1649 · Cited by 60
The proarrhythmic effect of hypoglycemia: evidence for increased risk from ischemia and bradycardia
Nordin, C. (2013) · Acta Diabetologica · doi:10.1007/s00592-013-0528-0 · Cited by 61
“The contemporary perspective on cardiovascular risks from hypoglycemia has been recently summarized in the report of the workgroup of the American Diabetes Association and the Endocrine Society [57].”
BackgroundGhouse, J., Isaksen, J. L., Skov, M. W., Lind, B., Svendsen, J. H., Kanters, J. K., OLESEN, M. S., Holst, A. G., & Nielsen, J. B. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13891 · Cited by 77
“Compared with older individuals without diabetes, those with T2D are at increased risk of premature death,(3) functional disabilities,(4) hypertension,(5) coronary heart disease,(6) stroke,(6) and other geriatric comorbidities, including cognitive impairment,(7) depression,(8) falls,(9) polypharmacy(10) and hypoglycae…”
BackgroundAdu, M. D., Malabu, U. H., Callander, E. J., Malau-Aduli, A. E., & Malau-Aduli, B. S. (2018) · JMIR mHealth and uHealth · doi:10.2196/10115 · Cited by 59
“Insulin overdose in diabetics can result to severe hypoglycemia and coma while under-dose can cause diabetes ketoacidosis; both can have fatal consequences [79,80].”
BackgroundImpact of occupational hearing loss on the lives of workers.
Hétu, R., Getty, L., & Quoc, H. T. (1995) · PubMed · Cited by 84
Diagnostic tools for post‐gastric bypass hypoglycaemia
Emous, M., Ubels, F. L., & van Beek, A. P. (2015) · Obesity Reviews · doi:10.1111/obr.12307 · Cited by 58
“However, the accuracy of CGM in the hypoglycaemic range is poor, and trends are more important than absolute concentrations (53).”
BackgroundDiabetes Mellitus, Cognitive Impairment, and Traditional Chinese Medicine
Seto, S. W., Yang, G., Kiat, H., Bensoussan, A., Kwan, Y. W., & Chang, D. (2015) · International Journal of Endocrinology · doi:10.1155/2015/810439 · Cited by 64
“For example, hypoglycemia is commonly observed in T1DM patients with tight glycemic control and in advanced T2DM patients [116, 117].”
BackgroundOlde Bekkink, M., Koeneman, M., de Galan, B. E., & Bredie, S. J. (2019) · Diabetes Care · doi:10.2337/dc18-1843 · Cited by 58
Henriksen, M. M., Andersen, H. U., Thorsteinsson, B., & Pedersen-Bjergaard, U. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00142 · Cited by 57
DeSouza, C., Cariou, B., Garg, S., Lausvig, N., Navarria, A., & Fonseca, V. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz072 · Cited by 57
Kaplan, W., & Afandi, B. O. (2015) · Diabetes Care · doi:10.2337/dc15-1108 · Cited by 57
Wang, J., Geiss, L. S., Williams, D. E., & Gregg, E. W. (2015) · PLOS ONE · doi:10.1371/journal.pone.0134917 · Cited by 57
“These findings indicate, as the American Diabetes Association, the Endocrine Society and the American Geriatrics Society [9,29] recommend, it is important to set individualized glycemic goals and to provide education to patients and their caregivers on proper use of insulin, recognizing hypoglycemia, and seeking treat…”
BackgroundProspective Study of Fasting Blood Glucose and Intracerebral Hemorrhagic Risk
Jin, C., Li, G., Rexrode, K. M., Gurol, M. E., Yuan, X., Hui, Y., Ruan, C., Vaidya, A., Wang, Y., Wu, S., et al. (2017) · Stroke · doi:10.1161/strokeaha.117.019189 · Cited by 64
Fulcher, G., Singer, J., Castañeda, R., Fraige Filho, F., Maffei, L., Snyman, J., & Brod, M. (2014) · Journal of Medical Economics · doi:10.3111/13696998.2014.946992 · Cited by 56
“Although most glucose-lowering medications increase the risk of hypoglycemia to some extent, the majority of episodes occur in people treated with glucose-lowering medications that raise insulin levels independently of blood glucose, such as sulfonylureas, glinides and insulins 21,22 .”
BackgroundEffect of Ranolazine Monotherapy on Glycemic Control in Subjects With Type 2 Diabetes
Eckel, R. H., Henry, R. R., Yue, P., Dhalla, A. K., Wong, P., Jochelson, P., Belardinelli, L., & Skyler, J. S. (2015) · Diabetes Care · doi:10.2337/dc14-2629 · Cited by 57
Klimontov, V. V., & Myakina, N. E. (2016) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2016.08.023 · Cited by 59
Buse, J. B., Carlson, A. L., Komatsu, M., Mosenzon, O., Rose, L., Liang, B., Buchholtz, K., Horio, H., & Kadowaki, T. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13545 · Cited by 56
Bode, B. W., & Garg, S. K. (2015) · Endocrine Practice · doi:10.4158/ep15869.ra · Cited by 56
Beato‐Víbora, P., Yeoh, E., Rogers, H., Hopkins, D., Amiel, S. A., & Choudhary, P. (2015) · Diabetic Medicine · doi:10.1111/dme.12869 · Cited by 55
Klen, J., Dolžan, V., & Janež, A. (2014) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-014-1641-x · Cited by 57
“Severe hypoglycemia was defined as any episode requiring assistance of another party [25, 26].”
Costs associated with emergency care and hospitalization for severe hypoglycemia
Veronese, G., Marchesini, G., Forlani, G., Saragoni, S., Esposti, L. D., Centis, E., & Fabbri, A. (2016) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2016.01.007 · Cited by 56
Epidemiology of diabetes mellitus
Mekala, K. C., & Bertoni, A. G. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814833-4.00004-6 · Cited by 97
Ji, L., Zhang, P., Zhu, D., Li, X., Ji, J., Lu, J., Guo, X., Jia, W., Weng, J., Wu, Y., et al. (2017) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12886 · Cited by 54
Karter, A. J., Lipska, K. J., O’Connor, P. J., Liu, J. Y., Moffet, H. H., Schroeder, E. B., Lawrence, J. M., Nichols, G. A., Newton, K. M., Pathak, R. D., et al. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.02.009 · Cited by 53
“Given the harms associated with SH, recent guidelines suggest that avoiding hypoglycemia should be prioritized over aggressive glycemic targets, particularly in older patients, (Seaquist et al., 2013) and measuring rates of SH as a diabetes care quality measure has been suggested.”
BackgroundNon-islet Cell Hypoglycemia: Case Series and Review of the Literature
Garla, V. V., Sonani, H., Palabindala, V., Gómez-Sánchez, C. E., Subauste, J. S., & Lien, L. F. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00316 · Cited by 59
Galindo, R. J., Ali, M. K., Funni, S. A., Dodge, A. B., Kurani, S. S., Shah, N. D., Umpierrez, G. E., & McCoy, R. G. (2022) · Diabetes Care · doi:10.2337/dc21-1579 · Cited by 53
Bruderer, S. G., Bodmer, M., Jick, S. S., Bader, G., Schlienger, R. G., & Meier, C. R. (2014) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12282 · Cited by 53
“by fast neurological recovery after glucose administration [1,5,15,16].”
BackgroundDiabetes mellitus type 2 in adults
Dedov, I. I., Shestakova, M. V., Mayorov, A. Y., Шамхалова, М. Ш., Sukhareva, O. Y., Galstyan, G. R., Tokmakova, A. Y., Nikonova, T. V., Surkova, E. V., Кононенко, И. В., et al. (2020) · Diabetes Mellitus · doi:10.14341/dm12507 · Cited by 69
Hassanein, M. M., Echtay, A. S., Hassoun, A. A. K., Alarouj, M., Afandi, B. O., Poladian, R., Bennakhi, A., Nazar, M., Bergmans, P., Keim, S., et al. (2017) · International Journal of Clinical Practice · doi:10.1111/ijcp.12991 · Cited by 56
Balijepalli, C., Druyts, E., Siliman, G., Joffres, M., Thorlund, K., & Mills, E. (2017) · Clinical Epidemiology · doi:10.2147/clep.s129268 · Cited by 52
Klein, K. R., Franek, E., Marso, S. P., Pieber, T. R., Pratley, R. E., Gowda, A., Kvist, K., & Buse, J. B. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002339 · Cited by 60
Mathiesen, E. R., Alibegovic, A. C., Corcoy, R., Dunne, F., Feig, D. S., Hod, M., Jia, T., Kalyanam, B., Kar, S., Kautzky-Willer, A., et al. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00307-2 · Cited by 52
Hypoglycemia in Patients with Type 1 Diabetes: Epidemiology, Pathogenesis, and Prevention
Awoniyi, O., Rehman, R., & Dagogo-Jack, S. E. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0411-y · Cited by 59
Self-citationCook, A. J., DuBose, S. N., Foster, N., Smith, E. L., Wu, M., Margiotta, G., Rickels, M. R., Speight, J., de Zoysa, N., & Amiel, S. A. (2019) · Diabetes Care · doi:10.2337/dc19-0002 · Cited by 52
“a question referring to the American Diabetes Association definition of SH (1): “How many episodes of hypoglycemia have you had in the last 12 months for which you were not able to treat yourself? (You had to have treatment from someone else, lost consciousness or had a seizure),” to which respondents selected a value…”
BackgroundMethodPatton, S. R., Clements, M. A., Marker, A. M., & Nelson, E. (2020) · Pediatric Diabetes · doi:10.1111/pedi.12934 · Cited by 52
“hypoglycemia symptoms.(2-4) For parents who are the primary caregiver of a very young child with type 1 diabetes, these factors contribute to very high rates of parental fear of hypoglycemia (FH).”
BackgroundKushimoto, S., Abe, T., Ogura, H., Shiraishi, A., Saitoh, D., Fujishima, S., Mayumi, T., Hifumi, T., Shiino, Y., Nakada, T., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0229919 · Cited by 58
Hypoglycemia From a Cardiologist's Perspective
Sanon, V. P., Sanon, S., Kanakia, R., Hu, Y., Araj, F., OLIVEROS, R. A., & CHILTON, R. J. (2014) · Clinical Cardiology · doi:10.1002/clc.22288 · Cited by 58
Barranco, R. J., Gomez‐Peralta, F., Abreu, C., Delgado, M., Palomares, R., Romero, F., Morales, C., de la Cal, M. A., Garcia‐Almeida, J. M., Pasquel, F., et al. (2015) · Diabetic Medicine · doi:10.1111/dme.12843 · Cited by 50
Liberal Glycemic Control in Critically Ill Patients With Type 2 Diabetes: An Exploratory Study
Kar, P., Plummer, M. P., Bellomo, R., Jenkins, A. J., Januszewski, A. S., Chapman, M. J., Jones, K. L., Horowitz, M., & Deane, A. M. (2016) · Critical Care Medicine · doi:10.1097/ccm.0000000000001815 · Cited by 54
“of hypoglycemia and also harm from hypoglycemia (20, 42).”
BackgroundMethodRidderstråle, M., Rosenstock, J., Andersen, K. R., Woerle, H. J., Salsali, A., & on behalf of the EMPA‐REG H2H‐SU trial investigators (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13457 · Cited by 51
“This constitutes a clinically meaningful advantage of empagliflozin over glimepiride, as hypoglycaemia poses serious health risks and can be a significant barrier to achieving glycaemic control.(13) Between week 104 and week 208, mean HbA1c gradually increased toward baseline levels in both treatment groups.”
BackgroundStage of change and motivation to healthy diet and habitual physical activity in type 2 diabetes
Centis, E., Trento, M., Dei, A., Pontiroli, A. E., Feo, P. D., Bruno, A., Sasdelli, A. S., Arturi, F., Strollo, F., de Kreutzenberg, S. V., et al. (2014) · Acta Diabetologica · doi:10.1007/s00592-013-0551-1 · Cited by 56
Cardiovascular Implications of Hypoglycemia in Diabetes Mellitus
Connelly, K. A., Yan, A. T.-K., Leiter, L. A., Bhatt, D. L., & Verma, S. (2015) · Circulation · doi:10.1161/circulationaha.115.015946 · Cited by 54
“9 mmol/L]).(3) Importantly, the sever-”
Deeb, L. C., Dulude, H., Guzman, C. B., Zhang, S., Reiner, B. J., Piché, C. A., Pradhan, S., & Zhang, X. M. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12668 · Cited by 50
Hypoglycemia in People with Type 2 Diabetes and CKD
Ahmad, I., Zelnick, L. R., Batacchi, Z., Robinson, N., Dighe, A., Manski-Nankervis, J.-A. E., Furler, J., O’Neal, D. N., Little, R., Trence, D., et al. (2019) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.11650918 · Cited by 49
“Demographics Age (years) 69 (10) 64 (10) 59 (10) Men 52 (64) 15 (62) 43 (59) Race/ethnicity White 60 (74) 20 (83) NA Black 12 (15) 2 (8) NA Other 9 (11) 2 (8) NA Hispanic ethnicity 8 (10) 3 (12) NA Highest level of education High school 22 (27) 7 (29) NA Trade school 17 (21) 7 (29) NA College 23 (28) 7 (29) NA Graduat…”
BackgroundInfluentialHeruc, G. A., Little, T. J., Kohn, M. R., Madden, S., Clarke, S. D., Horowitz, M., & Feinle‐Bisset, C. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00149.2018 · Cited by 55
Kaiser, N., Gautschi, M., Bošanská, L., Meienberg, F., Baumgartner, M. R., Spinas, G. A., & Hochuli, M. (2019) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2019.02.008 · Cited by 50
Haynes, A., Hermann, J. M., Clapin, H., Hofer, S. E., Karges, B., Jones, T. W., Davis, E. A., & Holl, R. W. (2019) · Diabetes Care · doi:10.2337/dc18-2448 · Cited by 49
Fear of hypoglycemia, a game changer during physical activity in type 1 diabetes mellitus patients
Berković, M. C., Bilić-Čurčić, I., Sabolić, L. L. G., Mrzljak, A., & Cigrovski, V. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i5.569 · Cited by 59
Dejgaard, T. F., von Scholten, B. J., Christiansen, E., Kreiner, F. F., Bardtrum, L., von Herrath, M., Mathieu, C., Madsbad, S., & ADJUNCT ONE and ADJUNCT TWO Investigators (2021) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14532 · Cited by 48
Noninvasive Hypoglycemia Detection in People With Diabetes Using Smartwatch Data
Lehmann, V., Föll, S., Maritsch, M., van Weenen, E., Kraus, M., Lagger, S., Odermatt, K., Albrecht, C., Fleisch, E., Zueger, T., et al. (2023) · Diabetes Care · doi:10.2337/dc22-2290 · Cited by 53
“Hypoglycemia is a frequent and dangerous complication of diabetes (1), causing changes in physiological parameters (2,3).”
BackgroundDei, A., Spigoni, V., Cito, M., Aldigeri, R., Ridolfi, V., Marchesi, E., Marina, M., Derlindati, E., Aloe, R., Bonadonna, R. C., et al. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0503-0 · Cited by 48
“Safety assessments included adverse events (AEs), incidence and severity of hypoglycemia [21], discontinuation for hyperglycemia (defined as HBA1C ≥ 8%; ≥63.”
BackgroundSchroeder, E. B., Xu, S., Goodrich, G. K., Nichols, G. A., O'Connor, P. J., & Steiner, J. F. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.04.004 · Cited by 46
Misra-Hebert, A. D., Pantalone, K. M., Ji, X., Milinovich, A., Dey, T., Chagin, K. M., Bauman, J. M., Kattan, M. W., & Zimmerman, R. S. (2018) · Diabetes Care · doi:10.2337/dc17-1834 · Cited by 46
“While documented or probable symptomatic hypoglycemia or asymptomatic hypoglycemia (16) may occur more commonly than severe hypoglycemia, the occurrence of severe hypoglycemia remains an important problem.”
BackgroundSchwartz, S. S., Herman, M. E., Tun, M. T. H., Barone, E., & Butterfield, D. A. (2024) · BMC Medicine · doi:10.1186/s12916-024-03763-8 · Cited by 55
“Elderly individuals are most likely to experience asymptomatic hypoglycemia [101].”
Recombinant Human Insulins – Clinical Efficacy and Safety in Diabetes Therapy
Landgraf, W., & SANDOW, J. (2016) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2016.12.01.12 · Cited by 60
Reporting Severe Hypoglycemia in Type 1 Diabetes: Facts and Pitfalls
Pedersen‐Bjergaard, U., & Thorsteinsson, B. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0965-1 · Cited by 52
Frias, J. P., Wynne, A. G., Matyjaszek‐Matuszek, B., Bartaskova, D., Cox, D. A., Woodward, B., Li, Y. G., Tham, L. S., & Milicevic, Z. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13764 · Cited by 46
“Events of hypoglycaemia were collected as described by Seaquist et al.20 (documented symptomatic, asymptomatic, probable symptomatic, severe, nocturnal and total).”
MethodInitiation and Titration of Basal Insulin in Primary Care: Barriers and Practical Solutions
Perreault, L., Vincent, L., Neumiller, J. J., & Cavaiola, T. S. (2019) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2019.03.180162 · Cited by 49
Pozzilli, P., Bosi, E., Cirkel, D., Harris, J., Leech, N., Tinahones, F. J., Vantyghem, M.-C., Vlasakakis, G., Ziegler, A.-G., & Janmohamed, S. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa149 · Cited by 45
Rondags, S. M. P. A., de Wit, M., Twisk, J. W., & Snoek, F. J. (2016) · Diabetes Care · doi:10.2337/dc16-1614 · Cited by 45
Mitchell, B. D., Vietri, J., Zagar, A., Curtis, B., & Reaney, M. (2013) · BMC Endocrine Disorders · doi:10.1186/1472-6823-13-59 · Cited by 44
“Patient characterizations of their most recent HE revealed that many did not test blood glucose during their episode, and a few claimed to have normal blood glucose levels during their HE, raising the question of whether all those in the HE group experienced a HE as defined by the American Diabetes Association criteri…”
MethodSejling, A., Kjær, T. W., Pedersen‐Bjergaard, U., Diemar, S. S., Frandsen, C. S., Hilsted, L., Faber, J. O., Holst, J. J., Tarnow, L., Nielsen, M. N., et al. (2014) · Diabetes · doi:10.2337/db14-1359 · Cited by 48
McNicholas, B., Pham, M. H., Carli, K., Chen, C. H., Smith, N. C., Anderson, A. E., & Pham, H. (2017) · Kidney International Reports · doi:10.1016/j.ekir.2017.10.009 · Cited by 50
“Hypoglycemia was defined as blood glucose < 70 mg/dl and severe hypoglycemia as blood glucose < 40 mg/dl within 6 hours of insulin treatment.(26) Acute kidney injury (AKI) was defined as a serum creatinine that was > 0.”
BackgroundResultGPR119 Agonism Increases Glucagon Secretion During Insulin-Induced Hypoglycemia
Li, N. X., Brown, S. N., Kowalski, T. J., Wu, M. S., Yang, L. M., Dai, G., Petrov, A., Ding, Y., Dlugos, T., Wood, H. B., et al. (2018) · Diabetes · doi:10.2337/db18-0031 · Cited by 45
“hypoglycemia is also accompanied by hypoglycemic autonomic failure, patients with T1DM become particularly vulnerable to iatrogenic hypoglycemia, including frequent dangerous bouts of nocturnal hypoglycemia that may increase during efforts to attain strict glycemic control (20,31,32).”
BackgroundAlsahli, M., & Gerich, J. E. (2013) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.07.002 · Cited by 53
Ajjan, R. A., Heller, S. R., Everett, C. C., Vargas-Palacios, A., Higham, R., Sharples, L., Gorog, D. A., Rogers, A., Reynolds, C., Fernandez, C., et al. (2023) · Diabetes Care · doi:10.2337/dc22-1219 · Cited by 44
“vention (26), in terms of cost and QOL.”
BackgroundSelf-citationImpact of pay-for-performance on mortality in diabetes patients in Taiwan: A population-based study
Chen, Y., Lee, C. T., Lin, B. J., Chang, Y., & Shi, H. (2016) · Medicine · doi:10.1097/md.0000000000004197 · Cited by 56
Rodbard, H. W., Tripathy, D., Vidrio-Velázquez, M., Demissie, M., Tamer, S. C., & Piletič, M. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12955 · Cited by 49
Forlenza, G. P., Argento, N. B., & Laffel, L. M. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0034 · Cited by 44
“21,26 Schu¨tt et al. reported that patients with T1D > 60 years old had nearly twice the incidence of SH compared to younger T1D patients 27 ; the T1DX reported that patients > 65 years old had a high rate of SH (0.168 episodes/patient-year).”
InfluentialHan, K., Yun, J., Park, Y., Ahn, Y., Cho, J., Cha, S., & Ko, S. (2018) · Clinical Epidemiology · doi:10.2147/clep.s169835 · Cited by 53
“It is categorized as mild if it is self-limiting and severe if it requires external assistance for recovery.(7) Only a small fraction of patients with T2DM with glycemic control experience severe hypoglycemia (SH) episodes.”
BackgroundThieu, V. T., Mitchell, B. D., Varnado, O. J., & Frier, B. M. (2020) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13941 · Cited by 44
“tions for HCPs include assessment of the risk of hypoglycaemia by clinicians and educators at every consultation with people who are being treated with insulin and insulin secretagogues, and have knowledge of the pharmacokinetics (PK) of medications.(41) People who have developed an impaired awareness of hypoglycaemia…”
BackgroundTatović, D., Marwaha, A., Taylor, P. N., Hanna, S. J., Carter, K., Cheung, W., Luzio, S. D., Dunseath, G. J., Hutchings, H. A., Holland, G., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-03115-2 · Cited by 60
Umezawa, S., Kubota, A., Maeda, H., Kanamori, A., Matoba, K., Jin, Y., Minagawa, F., Obana, M., Iemitsu, K., Ito, S., et al. (2015) · BMC Endocrine Disorders · doi:10.1186/s12902-015-0033-2 · Cited by 42
“Hypoglycemia was diagnosed if HbA1c was ≤ 70 mg/dL or typical hypoglycemic symptoms were confirmed by the primary physician, in conformity with the definition of the American Diabetes Association (ADA) [19].”
MethodKenny, C. (2013) · Primary care diabetes · doi:10.1016/j.pcd.2013.09.002 · Cited by 50
Pieber, T. R., Deller, S., Korsatko, S., Jensen, L., Christiansen, E., Madsen, J., & Heller, S. R. (2015) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12473 · Cited by 43
“Throughout the trial, hypoglycaemia was classified according to criteria proposed by an American Diabetes Association working group [31] [severe: an event requiring third-party assistance; documented symptomatic: measured blood glucose ≤3.”
MethodSelf-citationMuller, N., Khunti, K., Kuß, O., Lindblad, U., Nolan, J. J., Rutten, G. E. H. M., Trento, M., Porta, M., Roth, J., Charpentier, G., et al. (2016) · Acta Diabetologica · doi:10.1007/s00592-016-0939-9 · Cited by 47
“Particularly in these patients, hypo-glycaemia may even lead to reduced quality of life and serious consequences such as falls and accidents, dementia, cardiovascular disease and mortality [4–7].”
β Cell Replacement Therapy: The Next 10 Years
Schuetz, C., Anazawa, T., Cross, S. E., Labriola, L., Meier, R. P. H., Redfield, R. R., Scholz, H., Stock, P. G., & Zammit, N. W. (2017) · Transplantation · doi:10.1097/tp.0000000000001937 · Cited by 50
Clinical Evaluation of MK ‐2640: An Insulin Analog With Glucose‐Responsive Properties
Krug, A. W., Visser, S. A. G., Tsai, K., Kandala, B., Fancourt, C., Thornton, B., Morrow, L., Kaarsholm, N. C., Bernstein, H. S., Stoch, S. A., et al. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1215 · Cited by 43
Beck, R. W., Bergenstal, R. M., Riddlesworth, T. D., & Kollman, C. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0362 · Cited by 42
Challenges and strategies for managing diabetes in the elderly in long-term care settings
Pandya, N., Hames, E., & Sandhu, S. (2020) · Diabetes Spectrum · doi:10.2337/ds20-0018 · Cited by 42
Kim, Y., Rajan, K. B., Sims, S. A., Wroblewski, K., & Reutrakul, S. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.11.026 · Cited by 49
Evaluation and management of diabetic and non-diabetic hypoglycemia in end-stage renal disease
Gosmanov, A. R., Gosmanova, E. O., & Kovesdy, C. P. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv258 · Cited by 48
Patoulias, D., Doumas, M. N., Kotsis, V., Stavropoulos, K., Imprialos, K. P., Zografou, I., Petidis, K., Bakatselos, S., & Karagiannis, A. I. (2020) · Current Diabetes Reviews · doi:10.2174/1573399815666190614141918 · Cited by 53
Metadata
- Authors
- Seaquist, E. R., Anderson, J., Childs, B., Cryer, P., Dagogo-Jack, S., Fish, L., Heller, S. R., Rodriguez, H., Rosenzweig, J., & Vigersky, R.
- Affiliations
- University of Minnesota (US)
- The Frist Clinic, Nashville, Tennessee;
- Mid-America Diabetes Associates, Wichita, Kansas; the
- Washington University in St. Louis (US)
- University of Tennessee Health Science Center (US)
- Park Nicollet Clinic (US)
- University of Sheffield (GB)
- University of South Florida (US)
- Boston University (US)
- Walter Reed National Military Medical Center (US)
- Corresponding author
- Seaquist, Elizabeth R.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2013-04-13
- Volume
- 36
- Issue
- 5
- Pages
- 1384-1395
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3631867
- OpenAlex
- W2109416725
- Cited by
- 1,389
- References
- 141
- Citations by year
- 2026: 43 · 2025: 47 · 2024: 62 · 2023: 66 · 2022: 92 · 2021: 127 · 2020: 119 · 2019: 149 · 2018: 148 · 2017: 151 · 2016: 129 · 2015: 129 · 2014: 92 · 2013: 33
- FWCI
- 100.42
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- Eli Lilly and Company
- Sanofi
- National Institute for Health and Care Research (NF-SI-0611-10248)
- Novo Nordisk
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Patient Safety and Medication Errors
- Keywords
- hypoglycemia, diabetes mellitus, hypoglycemia definition, hypoglycemia prevention, long-term outcomes, patient counseling, clinical guidelines
- MeSH terms
- Diabetes Mellitus, Humans, Hypoglycemia, Societies, Medical, United States
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-30, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-30 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.